JAC Advance Access first published online on September 20, 2007
This version published online on September 27, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm356
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study
1 Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece 2 Department of Medicine, Tufts University School of Medicine, Boston, MA, USA 3 Department of Medicine, Henry Dunant Hospital, Athens, Greece 4 Department of Medicine, University Hospital of Heraklion, Heraklion, Greece 5 Intensive Care Unit, Henry Dunant Hospital, Athens, Greece 6 Department of Microbiology, Henry Dunant Hospital, Athens, Greece 7 Department of Microbiology, University Hospital of Heraklion, Heraklion, Greece
Received 7 June 2007; returned 27 July 2007; revised 17 August 2007; accepted 21 August 2007
* Correspondence address. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Greece. Tel: +30-694-611-0000; Fax: +30-210-683-9605; E-mail: m.falagas{at}aibs.gr
Background: Carbapenems are frequently used to treat infections due to extended-spectrum ß-lactamase-producing Klebsiella pneumoniae. Thus, the emergence of infections due to carbapenem-resistant K. pneumoniae (CRKp) is a major public health concern.
Objectives: To identify risk factors associated with the development of CRKp infections.
Methods: We conducted a matched case–control study in two hospitals (Henry Dunant Hospital, Athens, Greece and University Hospital of Heraklion, Crete, Greece). The controls were selected among patients with carbapenem-susceptible K. pneumoniae (CSKp) and were matched with CRKp cases for site of infection.
Results: One hundred and six patients were included in our study (53 cases and 53 controls). Mortality was 30.1% and 33.9% for patients with CRKp and CSKp infections, respectively (P = 0.83). Bivariable analysis showed that exposure to anti-pseudomonas penicillins (P = 0.004), carbapenems (P = 0.01), quinolones (P < 0.001) and glycopeptides (P < 0.001), as well as admission to the intensive care unit (P = 0.002), tracheostomy (P = 0.02), chronic obstructive pulmonary disease (P = 0.04), surgery with use of foreign body (P = 0.04) and mechanical ventilation (P = 0.02) were associated with CRKp infection. The multivariable analysis showed that exposure to fluoroquinolones [odds ratio (OR) 4.54, 95% confidence intervals (CIs) 1.78–11.54, P = 0.001] and exposure to antipseudomonal penicillins (OR 2.57, 95% CI 1.00–6.71, P = 0.04) were independent risk factors for CRKp infections.
Conclusions: Our data suggest that prior exposure to fluoroquinolones and antipseudomonal penicillins are independent risk factors for the development of CRKp infections.
Key Words: imipenem , meropenem , polymyxins , colistin , multidrug-resistant , mortality
The originally published version of this paper was incorrect. The surname of the third author was incorrect, it should have read Kofteridis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Goldfarb, S.-B. Harvey, K. Jessamine, P. Jessamine, B. Toye, and M. Desjardins Detection of Plasmid-Mediated KPC-Producing Klebsiella pneumoniae in Ottawa, Canada: Evidence of Intrahospital Transmission J. Clin. Microbiol., June 1, 2009; 47(6): 1920 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Z. Vardakas, I. I. Siempos, and M. E. Falagas Study conclusions should reflect results Can. Med. Assoc. J., March 31, 2009; 180(7): 738 - 738. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kelesidis, D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies J. Antimicrob. Chemother., November 1, 2008; 62(5): 895 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Schwaber, S. Klarfeld-Lidji, S. Navon-Venezia, D. Schwartz, A. Leavitt, and Y. Carmeli Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1028 - 1033. [Abstract] [Full Text] [PDF]
|
|